09.10.08 18:49 Age: 90 days
2008 Half-Year Results
Category: Investors
Results in line with expectations.
A first half-year marked by important advances.
Marseille, France, October 9th, 2008 - IPSOGEN SA (Alternext - FR0010626028 - ALIPS), a molecular diagnostic company specialized in the development, the manufacturing and the commercialization of diagnostic assays for breast cancer and leukemia, today announces its consolidated results for the first half-year ending June 2008.
For the first half of 2008, revenue totaled €1.55 M versus €1.09 M for the same period of 2007, an increase of +45.5 % at constant forex. At real currency rates, revenue growth was 41.6%.
More
